Ernexa Therapeutics Inc. (ERNA) stock
ERNANasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ERNAW
$1.93−0.08 (-3.98%)
Close on Nov 11, 2026Market cap $3.15MP/E –Yield –
Ernexa Therapeutics cash
Cash and short-term investments held at the end of each period.
Ernexa Therapeutics's cash was $5.58M at Sep 30, 2026. For fiscal 2025 it was $1.88M, up 9.0% from the year before. Over ten years it grew -5.2% a year on average. The highest annual figure on record is $16.99M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.88M | +9.0% |
| FY2024 | Dec 31, 2024 | $1.73M | -85.2% |
| FY2023 | Dec 31, 2023 | $11.67M | -24.9% |
| FY2022 | Dec 31, 2022 | $15.54M | -8.5% |
| FY2021 | Dec 31, 2021 | $16.99M | +942.0% |
| FY2020 | Dec 31, 2020 | $1.63M | -68.0% |
| FY2019 | Dec 31, 2019 | $5.10M | +101.1% |
| FY2018 | Dec 31, 2018 | $2.54M | -24.9% |
| FY2017 | Dec 31, 2017 | $3.38M | -40.6% |
| FY2016 | Dec 31, 2016 | $5.69M | +76.4% |
| FY2015 | Dec 31, 2015 | $3.22M | -55.1% |
| FY2014 | Dec 31, 2014 | $7.19M | +31.7% |
| FY2013 | Dec 31, 2013 | $5.46M | +100.5% |
| FY2012 | Dec 31, 2012 | $2.72M | +98.0% |
| FY2011 | Dec 31, 2011 | $1.37M | -64.8% |
| FY2010 | Dec 31, 2010 | $3.91M | +7.4% |
| FY2009 | Dec 31, 2009 | $3.64M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $5.58M | +83.0% |
| Q2 FY2026 | Jun 30, 2026 | $5.03M | +16.5% |
| Q1 FY2026 | Mar 31, 2026 | $9.18M | +378.5% |
| Q4 FY2025 | Dec 31, 2025 | $1.88M | +9.0% |
| Q3 FY2025 | Sep 30, 2025 | $3.05M | -28.5% |
| Q2 FY2025 | Jun 30, 2025 | $4.32M | +66.9% |
| Q1 FY2025 | Mar 31, 2025 | $1.92M | -62.5% |
| Q4 FY2024 | Dec 31, 2024 | $1.73M | -85.2% |
| Q3 FY2024 | Sep 30, 2024 | $4.26M | -6.3% |
| Q2 FY2024 | Jun 30, 2024 | $2.59M | +40.8% |
| Q1 FY2024 | Mar 31, 2024 | $5.12M | -5.2% |
| Q4 FY2023 | Dec 31, 2023 | $11.67M | -24.9% |
| Q3 FY2023 | Sep 30, 2023 | $4.55M | -65.7% |
| Q2 FY2023 | Jun 30, 2023 | $1.84M | -90.5% |
| Q1 FY2023 | Mar 31, 2023 | $5.40M | -77.0% |
| Q4 FY2022 | Dec 31, 2022 | $15.54M | -8.5% |
| Q3 FY2022 | Sep 30, 2022 | $13.25M | -45.6% |
| Q2 FY2022 | Jun 30, 2022 | $19.41M | -61.3% |
| Q1 FY2022 | Mar 31, 2022 | $23.50M | +179.4% |
| Q4 FY2021 | Dec 31, 2021 | $16.99M | +942.0% |
| Q3 FY2021 | Sep 30, 2021 | $24.38M | +698.1% |
| Q2 FY2021 | Jun 30, 2021 | $50.17M | +867.2% |
| Q1 FY2021 | Mar 31, 2021 | $8.41M | +137.9% |
| Q4 FY2020 | Dec 31, 2020 | $1.63M | -68.0% |
| Q3 FY2020 | Sep 30, 2020 | $3.06M | +20.6% |
| Q2 FY2020 | Jun 30, 2020 | $5.19M | +90.2% |
| Q1 FY2020 | Mar 31, 2020 | $3.54M | +32.6% |
| Q4 FY2019 | Dec 31, 2019 | $5.10M | +101.1% |
| Q3 FY2019 | Sep 30, 2019 | $2.53M | -17.7% |
| Q2 FY2019 | Jun 30, 2019 | $2.73M | -28.0% |
| Q1 FY2019 | Mar 31, 2019 | $2.67M | +1.2% |
| Q4 FY2018 | Dec 31, 2018 | $2.54M | -24.9% |
| Q3 FY2018 | Sep 30, 2018 | $3.08M | -31.0% |
| Q2 FY2018 | Jun 30, 2018 | $3.79M | -44.6% |
| Q1 FY2018 | Mar 31, 2018 | $2.64M | -56.9% |
| Q4 FY2017 | Dec 31, 2017 | $3.38M | -40.6% |
| Q3 FY2017 | Sep 30, 2017 | $4.46M | – |
| Q2 FY2017 | Jun 30, 2017 | $6.83M | – |
| Q1 FY2017 | Mar 31, 2017 | $6.11M | – |
| Q4 FY2016 | Dec 31, 2016 | $5.69M | – |
See a number that looks wrong?